Levels of anxiety and depression in patients with endometrial hyperplastic processes and extragenital pathology in the perimenopausal period

In: Wiadomości Lekarskie · 2024 · vol. 77(4) , pp. 690–695 · doi:10.36740/wlek202404112 · PMID:38865624 · W4399617400
article OA: closed CC0
View on OpenAlex View on PubMed View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-06-23

This study assessed anxiety and depression in 150 perimenopausal women, finding higher levels in those with endometrial hyperplasia and extragenital pathology compared to controls.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: Aim: The aim of the study was to determine the level of anxiety and depression in patients with endometrial hyperplastic processes and somatic pathology in the perimenopausal period. PATIENTS AND METHODS: Materials and Methods: Overall, 150 women who were split into 2 groups, participated in this study and answered on questionnaires that were conducted according to the Hospital Anxiety and Depression Scale (HADS) to assess the degree of anxiety and depressive symptoms in patients. PHQ-2 and PHQ-9 questionnaires were used to study the level of anxiety and depression. RESULTS: Results: Analysis of the results obtained using the HADS scale revealed that both anxiety and depressive symptoms in patients of the main group were more pronounced than in women of the control group. Identification of psycho-emotional disorders is the result of adverse effects of somatic diseases and gynecological pathology. CONCLUSION: Conclusions: The results of the study indicate the need to correct psycho-emotional disorders and take them into account when choosing a method of treatment in such patients.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

References (17)

Source provenance

openalex
last seen: 2026-05-10T10:31:24.809595+00:00
unpaywall
last seen: 2026-09-08T06:30:58.725006+00:00
License: CC0 · commercial use OK